D.A. Davidson & Co’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-24,250
Closed -$126K 1420
2023
Q1
$126K Sell
24,250
-19,350
-44% -$139K ﹤0.01% 1262
2022
Q4
$324K Buy
43,600
+26,050
+148% +$235K ﹤0.01% 1018
2022
Q3
$220K Buy
17,550
+3,000
+21% +$35.8K ﹤0.01% 1131
2022
Q2
$112K Buy
+14,550
New +$122K ﹤0.01% 1215

Other funds holding SRTS

D.A. Davidson & Co's SRTS Position: Q2 2023 in Review

D.A. Davidson & Co sold out of Sensus Healthcare (SRTS) in Q2 2023, closing a stake of 24,250 shares — an estimated $126K sold.

D.A. Davidson & Co first reported a position in SRTS in Q2 2022 and held it in 4 quarters. The position peaked at $324K in Q4 2022. 49 funds tracked by Wall St. Rank hold SRTS as of Q2 2023.

  • D.A. Davidson & Co reported no remaining Sensus Healthcare position as of Q2 2023 after selling out during the quarter.
  • D.A. Davidson & Co sold 24,250 Sensus Healthcare shares in Q2 2023, an estimated $126K.
  • D.A. Davidson & Co first reported a position in Sensus Healthcare in Q2 2022 and held it in 4 quarters.
  • D.A. Davidson & Co's Sensus Healthcare position peaked at $324K in Q4 2022.
  • 49 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2023.

Based on D.A. Davidson & Co's 13F filing for Q2 2023, filed 11 Aug 2023.